News & AnalysisBiofourmis nets $300Biofourmis, a provider of virtual care and digital medicine, has secured $300 million in Series D funding.ByIris Dorbian26 April 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs